PRKCE and neoplasm: 0.2-fold lowered PKCε expression in the distant metastasis group and 0.11-fold in advanced stage Tumors compared to the non-metastatic and lower-stage Tumor groups, in which PKCε expression was reduced by 0.1-fold and 0.6-fold, respectively.